Advanced glycation end products and lipofuscin deposits share the same location in cardiocytes of the failing heart

Experimental Gerontology

Volumn 48, Issue 2, 2013, Pages 223-228

  Nozynski, Jerzy ^a   Zakliczynski, Michael ^a   Konecka Mrowka, Dominika ^a   Zakliczynska, Helena ^a   Pijet, Marta ^a   Zembala Nozynska, Ewa ^b   Lange, Dariusz ^b   Zembala, Marian ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Advanced glycation end product; Cardiomyopathy; Computer assisted image analysis; Heart failure; Lipofuscin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; LIPOFUSCIN;

ADULT; ARTICLE; AUTOFLUORESCENCE; AUTOPSY; CARDIOCYTE; CONTROLLED STUDY; DIABETIC PATIENT; EXPLANT; FEMALE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DONOR; PRIORITY JOURNAL;

ADULT; AUTOPSY; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOFUSCIN; MALE; MIDDLE AGED; MYOCYTES, CARDIAC;

EID: 84872803634     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.09.002     Document Type: Article

References (38)

1. Abeywickrama C., Matsuda H., Jockusch S., Zhou J., Jang Y.P., Chen B.X., Itagaki Y., Erlanger B.F., Nakanishi K., Turro N.J., Sparrow J.R. Immunochemical recognition protein of A2E, a pigment in the lipofuscin of retinal pigment epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14610-14615.
2. Baynes J.W. The Maillard hypothesis of aging: time to focus on DNA. Ann. N. Y. Acad. Sci. 2002, 959:360-367.
3. Bolte S., Cordelières F.P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 2006, 224:213-232.
4. De Meyer G.R., Martinet W. Autophagy in the cardiovascular system. Biochim. Biophys. Acta 2009, 1793:1485-1495.
5. Dei R., Takeda A., Niwa H., Li M., Nakagomi Y., Watanabe M., Inagaki T., Washimi Y., Yasuda Y., Horie K., Miyata T., Sobue G. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol. 2002, 104:113-122.
6. Donaldson C., Taatjes D.J., Zile M., Palmer B., VanBuren P., Spinale F., Maughan D., Von Turkovich M., Bishop N., LeWinter M.M. Combined immunoelectron microscopic and computer-assisted image analyses to detect advanced glycation end-products in human myocardium. Histochem Cell Biol. 2010, 134:23-30.
7. Dunlop R.A., Brunk U.T., Rodgers K.J. Oxidized proteins: mechanisms of removal and consequences of accumulation. IUBMB Life 2009, 61:522-527.
8. Falcão-Pires I., Palladini G., Gonçalves N., van der Velden J., Moreira-Gonçalves D., Miranda-Silva D., Salinaro F., Paulus W.J., Niessen H.W., Perlini S., Leite-Moreira A.F. Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure overload. Basic Res. Cardiol. 2011, 106:801-814.
9. Horie K., Miyata T., Maeda K., Miyata S., Sugiyama S., Sakai H., Ypersole Van, de Strihou C., Monnier V.M., Witztum J.L., Kurokawa K. Immunohistochemical colocalization of glycooxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implications for glucoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin. Invest. 1997, 100:2995-3004.
10. Horie K., Miyata T., Yasuda T., Takeda A., Yasuda Y., Maeda K., Sobue G., Kurokawa K. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem. Biophys. Res. Commun. 1997, 236:327-332.
11. Jobst K., Lakatos A. The liver cell histones of diabetic patients contain glycation end products (AGEs) which may be lipofuscin components. Clin. Chim. Acta 1996, 256:203-204.
12. Jolly R.D., Palmer D.N., Dalefield R.R. The analytical approach to the nature of lipofuscin (age pigment). Arch. Gerontol. Geriatr. 2002, 34:205-217.
13. Jomova K., Vondrakova D., Lawson M., Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010, 345:91-104.
14. Jung T., Bader N., Grune T. Lipofuscin: formation, distribution, and metabolic consequences. Ann. N. Y. Acad. Sci. 2007, 1119:97-111.
15. Jung T., Höhn A., Grune T. Lipofuscin: detection and quantification by microscopic techniques. Methods Mol. Biol. 2010, 594:173-193.
16. Kass D.A. Getting better without AGE. New insights into the diabetic heart. Circ. Res. 2003, 92:704-706.
17. Katare R., Oikawa A., Riu F., Beltrami A.P., Cesseli D., Emanueli C., Madeddu P. Diabetes induces maladaptative autophagy in cardiomyocytes and resident cardiac stem cells. Cardiovasc. Res. 2012, 93(Suppl. 1):S95. (P490).
18. Kostin S., Pool L., Elässer A., Hein S., Drexler H.C.A., Arnon E., Hayakawa Y., Zimmermann R., Bauer E., Klövekorn W.-P., Schaper J. Myocytes die by multiple mechanisms in failing human hearts. Circ. Res. 2003, 92:715-724.
19. Ling X., Sakashita N., Takeya M., Nagai R., Horiuchi S., Takahashi K. Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues. Lab. Invest. 1998, 78:1591-1606.
20. Ling X., Nagai R., Sakashita N., Takeya M., Horiuchi S., Takahashi K. Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats with streptozotocin-induced diabetes. Lab. Invest. 2001, 81:845-861.
21. Misra M.K., Sarwat M., Bhakuni P., Tuteja R., Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med. Sci. Monit. 2009, 15:RA209-RA219.
22. Nożyński J., Zakliczyński M., Konecka-Mrówka D., Nikiel B., Mlynarczyk-Liszka J., Zembala-Nożyńska E., Lange D., Maruszewski M., Zembala M. Advanced glycation end products in the development of ischemic and dilated cardiomyopathy in patients with diabetes mellitus type 2. Transplant. Proc. 2009, 41:99-104.
23. Nożyński J., Zakliczyński M., Konecka-Mrówka D., Przybylski R., Zembala M., Zielińska T., Mrówka A., Lange D., Zembala-Nożyńska E., Nikiel B., Młynarczyk-Liszka J. Advanced glycation end-products in myocardium-supported vessels: effects of heart failure and diabetes mellitus. J. Heart Lung Transplant. 2011, 30:558-564.
24. Otsuka K., Terasaki F., Shimomura H., Tsukada B., Horii T., Isomura T., Suma H., Shibayama Y., Kitaura Y. Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress. Heart Vessel. 2010, 25:474-484.
25. Parson S., Russell S.D., Bennett M.K., Dunn J.M., Gilotra N.A., Rao S., Harrington C., Freitag T.B., Foster M.C., Halushka M.K. Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults. Cardiovasc. Pathol. 2012, 4:317-323.
26. Powell S.R., Wang P., Divald A., Teichberg S., Haridas V., McCloskey T.W., Davies K.J., Katzeff H. Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic. Biol. Med. 2005, 38:1093-1101.
27. Schutt F., Bergmann M., Holz F.G., Kopitz J. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2003, 44:3663-3668.
28. Seehafer S.S., Pearce D.A. You say lipofuscin, we say ceroid: defining autofluorescent storage material. Neurobiol. Aging 2006, 27:576-588.
29. Soleiman A., Lukschal A., Hacker S., Aumayr K., Hoetzenecker K., Lichtenauer M., Moser B., Untersmayr E., Horvat R., Ankersmit H.J. Myocardial lipofuscin-laden lysosomes contain the apoptosis marker caspase-cleaved cytokeratin-18. Eur. J. Clin. Invest. 2008, 38:708-712.
30. Soliman D., Hamming K.S., Matemisz L.C., Light P.E. Reactive oxygen species directly modify sodium-calcium exchanger activity in a splice variant-dependent manner. J. Mol. Cell. Cardiol. 2009, 47:595-602.
31. Sugaya A., Sugimioto H., Mogi N., Tsujigami H., Deguchi S. Experimental diabetes accelerates accumulation of fluorescent pigments in rat trigeminal neurons. Brain Res. 2004, 999:132-134.
32. Sun A., Liu M., Bing G. Improving the specificity of immunological detection in aged human brain tissue samples. Int. J. Physiol. Pathophysiol. Pharmacol. 2011, 2:29-35.
33. Terman A., Brunk U.T. On the degradability and exocytosis of ceroid/lipofuscin in cultured rat cardiac myocytes. Mech. Ageing Dev. 1998, 100:145-156.
34. Terman A., Brunk U.T. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc. Res. 2005, 68:355-365.
35. Terman A., Kurz T., Navratil M., Arriaga E.A., Brunk U.T. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal. 2010, 12:503-535.
36. Thorpe R.S., Baynes J.W. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 2003, 25:275-281.
37. Younce C.W., Wang K., Kolattukudy P.E. Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP. Cardiovasc. Res. 2010, 87:665-674.
38. Zakliczynski M., Nozynski J., Konecka-Mrowka D., Krynicka-Mazurek A., Swierad M., Maruszewski M., Przybylski R., Zembala M. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?. J. Thorac. Cardiovasc. Surg. 2009, 138:215-221.